# Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

> **NCT01294020** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 81 (actual)

## Conditions studied

- Intestine Transplantation
- Kidney Transplantation
- Lung Transplantation
- Liver Transplantation
- Heart Transplantation

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Tacrolimus prolonged release

## Key facts

- **NCT ID:** NCT01294020
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-25
- **Primary completion:** 2015-10-25
- **Final completion:** 2025-11-03
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294020, "Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01294020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*